Skin Diseases, Papulosquamous

• For additional information regarding investigative sites for this trial, contact Kyowa Kirin — Chiyoda-ku, Tokyo, Japan

• AOU Policlinico G. Rodolico — Catania, Italy

• Guangdong Provincial Hospital of Traditional Chinese Medicine — Guangzhou, Guangdong, China

• Guangdong Provincial Hospital of Traditional Chinese Medicine — Guangzhou, Guangdong, China

• Guangdong Provincial Hospital of Traditional Chinese Medicine — Guangzhou, Guangdong, China

• Novartis Investigative Site — Birmingham, Alabama, United States
• Novartis Investigative Site — Thousand Oaks, California, United States
• Novartis Investigative Site — Cromwell, Connecticut, United States
• Novartis Investigative Site — Jacksonville, Florida, United States

• HOP Saint-Louis — Paris, France
• Nagoya City University Hospital — Aichi, Nagoya, Japan
• Hospital Sultanah Aminah — Johor Bahru, Malaysia
• Pusan National Univ. Hosp — Busan, South Korea

• UC Irvine Dermatology Clinical Research Center — Irvine, California, United States
• Wake Forest University School of Medicine — Winston-Salem, North Carolina, United States
• Dermatology Associates, PLLC — Seattle, Washington, United States

• B.J Medical College & Civil Hospital — Ahmedabad, Gujarat, India
• Kempegowda Institute of Medical Sciences — Bangalore, Karnataka, India
• Sapthagiri Hospital — Bangalore, Karnataka, India
• Triveni Polyclinic — Nagpur, Maharashtra, India

Not specified